Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05615246 · ClinicalTrials.gov registry record
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
A clinical trial, sponsored by Exactech.
- Terminated
- Registry status
- 4
- Enrollment target
NCT05615246: Clinical Trial study, sponsored by Exactech.
NCT05615246 is a clinical trial that was terminated before completion, run by Exactech. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05615246 was terminated before completion, sponsored by Exactech.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The objective of this study is to collect and evaluate long-term clinical outcomes data in order to better understand the safety and performance of the Equinoxe Humeral Reconstruction Prosthesis in shoulder arthroplasty over time. This study will follow subjects for a period of up to 10 years post-surgery.
Primary Outcome
Shoulder Simple Test (SST) - 12 questions with yes/no responses that measure shoulder pain and function from a patient's perspective - 12 yes corresponds to 100%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2024-09-25 |
Why NCT05615246 stopped before completion
NCT05615246 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05615246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05615246 about?
NCT05615246 is a clinical study titled "Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)". The objective of this study is to collect and evaluate long-term clinical outcomes data in order to better understand the safety and performance of the Equinoxe Humeral Reconstruction Prosthesis in shoulder arthroplasty over time. This study will follow subjects for a period of up to 10 years post-s...
What is the current status of trial NCT05615246?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2018-09-05. Estimated completion is 2024-09-25.
Who is sponsoring clinical trial NCT05615246?
This trial is sponsored by Exactech, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI